| Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries … AB Brueggemann, MJJ van Rensburg, D Shaw, ND McCarthy, KA Jolley, ... The Lancet Digital Health 3 (6), e360-e370, 2021 | 375 | 2021 |
| The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome … M Unemo, D Golparian, L Sánchez-Busó, Y Grad, S Jacobsson, ... Journal of Antimicrobial Chemotherapy 71 (11), 3096-3108, 2016 | 290 | 2016 |
| Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey SR Harris, MJ Cole, G Spiteri, L Sánchez-Busó, D Golparian, ... The Lancet Infectious Diseases 18 (7), 758-768, 2018 | 194 | 2018 |
| An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015 J Lucidarme, KJ Scott, R Ure, A Smith, D Lindsay, B Stenmark, ... Eurosurveillance 21 (45), 30395, 2016 | 127 | 2016 |
| Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015 MJ Cole, G Spiteri, S Jacobsson, N Woodford, F Tripodo, AJ Amato-Gauci, ... BMC infectious diseases 17, 1-9, 2017 | 101 | 2017 |
| WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014 S Jacobsson, D Golparian, M Cole, G Spiteri, I Martin, T Bergheim, ... Journal of antimicrobial chemotherapy 71 (11), 3109-3116, 2016 | 101 | 2016 |
| Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017 M Krone, S Gray, R Abad, A Skoczyńska, P Stefanelli, A van der Ende, ... Eurosurveillance 24 (14), 1800245, 2019 | 90 | 2019 |
| Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016 MJ Day, G Spiteri, S Jacobsson, N Woodford, AJ Amato-Gauci, MJ Cole, ... BMC infectious diseases 18, 1-8, 2018 | 80 | 2018 |
| High In Vitro Activity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a … S Jacobsson, D Golparian, RA Alm, M Huband, J Mueller, JS Jensen, ... Antimicrobial agents and chemotherapy 58 (9), 5585-5588, 2014 | 79 | 2014 |
| Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease S Jacobsson, ST Hedberg, P Mölling, M Unemo, M Comanducci, ... Vaccine 27 (10), 1579-1584, 2009 | 72 | 2009 |
| Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens S Jacobsson, S Thulin, P Mölling, M Unemo, M Comanducci, R Rappuoli, ... Vaccine 24 (12), 2161-2168, 2006 | 69 | 2006 |
| Meningococcal serogroup Y disease in Europe: continuation of high importance in some European regions in 2013 M Bröker, S Emonet, C Fazio, S Jacobsson, M Koliou, M Kuusi, D Pace, ... Human vaccines & immunotherapeutics 11 (9), 2281-2286, 2015 | 68 | 2015 |
| Direct and Rapid Identification and Genogrouping of Meningococci and porA Amplification by LightCycler PCR P Mölling, S Jacobsson, A Bäckman, P Olcén Journal of Clinical Microbiology 40 (12), 4531-4535, 2002 | 66 | 2002 |
| Decreased susceptibility to chlorhexidine and prevalence of disinfectant resistance genes among clinical isolates of Staphylococcus epidermidis G Prag, K Falk‐Brynhildsen, S Jacobsson, B Hellmark, M Unemo, ... Apmis 122 (10), 961-967, 2014 | 63 | 2014 |
| In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae S Jacobsson, D Golparian, N Scangarella-Oman, M Unemo Journal of Antimicrobial Chemotherapy 73 (8), 2072-2077, 2018 | 62 | 2018 |
| Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance MJ Cole, G Spiteri, S Jacobsson, R Pitt, V Grigorjev, M Unemo, ... BMC infectious diseases 15, 1-8, 2015 | 61 | 2015 |
| High In Vitro Susceptibility to the Novel Spiropyrimidinetrione ETX0914 (AZD0914) among 873 Contemporary Clinical Neisseria gonorrhoeae Isolates from 21 … M Unemo, J Ringlander, C Wiggins, H Fredlund, S Jacobsson, M Cole Antimicrobial agents and chemotherapy 59 (9), 5220-5225, 2015 | 61 | 2015 |
| In Vitro Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant … S Jacobsson, S Paukner, D Golparian, JS Jensen, M Unemo Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 01497-17, 2017 | 59 | 2017 |
| Meningococcal serogroup Y emergence in Europe: update 2011 M Bröker, S Jacobsson, M Kuusi, D Pace, MJ Simões, A Skoczynska, ... Human vaccines & immunotherapeutics 8 (12), 1907-1911, 2012 | 58 | 2012 |
| Genetic resistance determinants, in vitro time-kill curve analysis and pharmacodynamic functions for the novel topoisomerase II inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae S Foerster, D Golparian, S Jacobsson, LJ Hathaway, N Low, WM Shafer, ... Frontiers in microbiology 6, 164752, 2015 | 56 | 2015 |
